{"id":3897,"date":"2026-01-28T17:09:29","date_gmt":"2026-01-28T08:09:29","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/?page_id=3897"},"modified":"2026-01-29T12:51:06","modified_gmt":"2026-01-29T03:51:06","slug":"publications","status":"publish","type":"page","link":"https:\/\/atlas.ncc.go.jp\/en\/clinical_trial\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Year of Publication<\/td>\r\nLanguage<\/td>\r\nCategory<\/td>\r\nDetails<\/td>\r\n<\/tr>\r\n
FY2021<\/td>\r\nEnglish<\/td>\r\n(1) Articles Published in Academic Journals and Magazines<\/td>\r\nHata T, Nakamura K, Yonemori K, Noguchi E, Watanabe M, Sohn J, Lu Y, Yap Y, Tamura K, Fujiwara Y. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs. Clin Transl Sci. 2021;00:1-11, DOI:10.1111\/cts.12965.\u00a0<\/td>\r\n<\/tr>\r\n
FY2021<\/td>\r\nEnglish<\/td>\r\n(1) Articles Published in Academic Journals and Magazines<\/td>\r\nShimizu T, Kim DW, Loong HH, Lin CC, Yamamoto N, Matthew N, Brigette M, Tan DSW. Overcoming Distress and Challenges against COVID-19 Impact on Oncology Early Phase Trials and Drug Development \u2013 Experiences and Perspectives from Asian Oncology Early Phase 1 Consortium \u2013Asia Pac J Clin Oncol 17:388-395, 2021. doi: 10.1111\/ajco.13510.\u00a0<\/td>\r\n<\/tr>\r\n
FY2021<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\n\u4e2d\u6751 \u5065\u4e00. Development of Asian Clinical Trial Network (ATLAS project). DIA Japan Annual Meeting 2021. 2021\/10\/24 \u56fd\u5185\u3001\u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2021<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\n\u7c73\u76db \u52e7. Imagine! the cancer research and clinical trial within Asia, by Asian for Asians. ATLAS\u3067\u9032\u3081\u3088\u3046\uff01\u30a2\u30b8\u30a2\u306e\u3001\u30a2\u30b8\u30a2\u306b\u3088\u308b\u3001\u30a2\u30b8\u30a2\u306e\u305f\u3081\u306e\u304c\u3093. \u7b2c19\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2022\/2\/17 \u56fd\u5185\u3001\u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2021<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nMitsumi Terada, ATLAS project and the role of NCC Asian Partnerships Office in Bangkok, 6th Global Clinical Trial Advanced and Planning Symposium\uff08\u7b2c6\u56de \u56fd\u969b\u5171\u540c\u81e8\u5e8a\u7814\u7a76\u63a8\u9032\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09, 2022\/03\/03, \u56fd\u5185, \u53e3\u6f14\u00a0<\/td>\r\n<\/tr>\r\n
FY2022<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\n\u4e2d\u6751 \u5065\u4e00. Overview of the ATLAS project. \u65e5\u53f0\u56fd\u969b\u533b\u7642\u4ea4\u6d41\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0. 2022\/9\/3 \u56fd\u5185\u3001\u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2022<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\n\u4e2d\u6751 \u5065\u4e00. \u30a2\u30b8\u30a2\u5730\u57df\u306e\u56fd\u969b\u9023\u643a\u306e\u305f\u3081\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u69cb\u7bc9. ARO\u5354\u8b70\u4f1a 2022\/9\/16. \u56fd\u5185\u3001\u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2022<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nKenichi NAKAMURA. ATLAS project-leading the world\u2019s early drug development. CRM Connect 2022. 2022\/10\/15, \u6d77\u5916, \u53e3\u6f14\u00a0<\/td>\r\n<\/tr>\r\n
FY2022<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nKenichi NAKAMURA. Establishment of Asian Clinical Trial Network: ATLAS. 33rd ASCOMOS Annual Meeting. 2022\/11\/5, \u6d77\u5916, \u53e3\u6f14\u00a0<\/td>\r\n<\/tr>\r\n
FY2022<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nKenichi NAKAMURA. Empowering clinical trials in a globalized world. DIA China 2022. 2022\/12\/10, \u6d77\u5916, \u53e3\u6f14\u00a0<\/td>\r\n<\/tr>\r\n
FY2022<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\n\u5bfa\u7530\u53c2\u7701. Asian Clinical Trials Network for Cancers Project (ATLAS). \u7b2c7\u56de \u56fd\u969b\u5171\u540c\u81e8\u5e8a\u7814\u7a76\u63a8\u9032\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0. 2023\/3\/9, \u56fd\u5185, \u53e3\u6f14\u00a0<\/td>\r\n<\/tr>\r\n
FY2022<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nKenichi NAKAMURA. Regulatory challenges in academic clinical trials intended for pharmaceutical application. JSMO Annual Meeting 2023. 2023\/3\/16, \u56fd\u5185, \u53e3\u6f14\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nEnglish<\/td>\r\n(1) Articles Published in Academic Journals and Magazines<\/td>\r\nOkuma HS, Yoshida H, Kobayashi Y, Arakaki M, Mizoguchi C, Inagaki L, Voon PJ, Malik Bin Ismail A, Fen Soo Hoo H, Yusak S, Severino B Imasa M, Nguyen Huy T, Thai Anh T, Kohsaka S, Mano H, Yonemori K, Nakamura K, Yatabe Y. Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia. Cancer Sci. 2023 Jun;114(6):2664-2673.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nJapanese<\/td>\r\n(1) Articles Published in Academic Journals and Magazines<\/td>\r\n\u4e2d\u6751\u5065\u4e00. \u30a2\u30b8\u30a2\u304c\u3093\u81e8\u5e8a\u8a66\u9a13\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u4e8b\u696d\uff08ATLAS\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\uff09\u306e\u671f\u5f85\u3068\u8ab2\u984c. \u764c\u3068\u5316\u5b66\u7642\u6cd5. 2023, 50(8), 839-44.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nEnglish<\/td>\r\n(1) Articles Published in Academic Journals and Magazines<\/td>\r\nTerada M, Nakamura K, Matsuda T, Okuma HS, Sudo K, Yusof A, Imasa M, Sirachainan E, Anh PT, Fujiwara Y, Yamamoto N, Voon PJ, Chokephaibulkit K, Shibata T, Inoue M, Mano H, Shimoi T, Sriuranpong V, Yonemori K, Shimada K. A new era of the Asian clinical research network: a report from the ATLAS international symposium. Japanese journal of clinical oncology. 2023;53(7):619-28.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\n\u30a2\u30b8\u30a2\u304c\u3093\u81e8\u5e8a\u8a66\u9a13\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3068DCT\u306e\u53d6\u308a\u7d44\u307f, \u4e2d\u6751\u5065\u4e00, \u30ec\u30ae\u30e5\u30e9\u30c8\u30ea\u30fc\u30b5\u30a4\u30a8\u30f3\u30b9\u5b66\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, 2023\/5\/30, \u56fd\u5185, \u53e3\u982d.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\n\u30a2\u30b8\u30a2\u304c\u3093\u81e8\u5e8a\u8a66\u9a13\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u4e8b\u696d\u306e\u73fe\u5728\u5730, \u4e2d\u6751\u5065\u4e00, \u7b2c13\u56de\u30ec\u30ae\u30e5\u30e9\u30c8\u30ea\u30fc\u30b5\u30a4\u30a8\u30f3\u30b9\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2023\/9\/8, \u56fd\u5185, \u53e3\u982d.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nFully Decentralized Clinical Trials in Oncology, Kenichi NAKAMURA, ICH E6(R3) public web conference, 2023\/9\/12, \u56fd\u5916, \u53e3\u982d.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nCollaboration with Thailand through ATLAS Project, Kenichi NAKAMURA, 10th Thailand-Japan Symposium, 2024\/1\/16, \u56fd\u5916, \u53e3\u982d.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nOperational challenges for International Investigator-Initiated Clinical Trials in Oncology, T Hata, C Mizoguchi, P Promsurin, M Terada, L Inagaki, T Sasaki, K Abe, H Okuma, N Okita, K Nakamura, SOCRA 2023 Annual Conference. 2023\/9\/30, \u30dd\u30b9\u30bf\u30fc\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nA platform study for rare cancers: MASTER KEY Japan and Asia, Okuma H, 2023 DIA Asia Meeting, 2023\/9\/13, Beijing, China, Oral.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nA platform study for rare cancers: MASTER KEY Asia, Okuma H, 2023 CHA International CT Symposium, 2023\/11\/7, Korea, Oral.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nThe ATLAS Clinical Trial Platform, Mitsumi T, 2nd ANCCA Annual Scientific Conference 2023, 3 Nov 2023, Singapore, Oral.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nTanitame M, Hirabayashi M. Cholangiocarcinoma Epidemiology in Japan. TSCO-ATLAS Cholangiocarcinoma Symposium. 2023\/9\/16, \u56fd\u5916, \u53e3\u982d.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nChigusa Morizane. Treatment and Care for Cholangiocarcinoma -Molecular & Immunotherapy. TSCO-ATLAS Cholangiocarcinoma Symposium. 2023\/9\/16, \u56fd\u5916, \u53e3\u982d.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nSatoshi Nara, Esaki M, Ban D, Takamot T, Mizui T, Shimada K. JCOG studies for cholangiocarcinoma. TSCO-ATLAS Cholangiocarcinoma Symposium. 2023\/9\/16, \u56fd\u5916, \u53e3\u982d.\u00a0<\/td>\r\n<\/tr>\r\n
FY2023<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nMaruki Y. TR and Clinical Research on Cholangiocarcinoma -Choice Study. TSCO-ATLAS Cholangiocarcinoma Symposium. 2023\/9\/16, \u56fd\u5916, \u53e3\u982d.\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nJapanese<\/td>\r\n(1) Articles Published in Academic Journals and Magazines<\/td>\r\n\u5bfa\u7530\u3000\u53c2\u7701\u3001\u4e2d\u6751\u3000\u5065\u4e00. ATLAS\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u3000\u816b\u760d\u5185\u79d1\u3000\u7b2c34\u5dfb\u7b2c1\u53f7\uff082024\u5e747\u6708\u53f7\uff0972-78\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nJapanese<\/td>\r\n(1) Articles Published in Academic Journals and Magazines<\/td>\r\n\u5bfa\u7530\u3000\u53c2\u7701\u3001\u4e2d\u6751\u3000\u5065\u4e00. \u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u56fd\u969b\u5171\u540c\u8a66\u9a13\u306e\u73fe\u72b6\u3068\u8ab2\u984c\u3000\u8840\u6db2\u5185\u79d1 \u7b2c88\u5dfb\u7b2c4\u53f7\uff082024\u5e744\u6708\u53f7\uff09419-425\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(1) Articles Published in Academic Journals and Magazines<\/td>\r\nEmi Noguchi… Kan Yonemori. A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive\/HER2-negative advanced breast cancer. NPJ breast cancer 10(1) 76-76 2024\u5e748\u670822\u65e5\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(1) Articles Published in Academic Journals and Magazines<\/td>\r\nMomoko Tokura… Sho Shiino. Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study. Breast cancer : basic and clinical research 18 2024\u5e74\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(1) Articles Published in Academic Journals and Magazines<\/td>\r\nSekiguchi M, Shinmura K, Sumiyama K, Matsuda T, Han KS, Kim HS, Chiu HM, Chang CY, Lee WJJ, Khor CJL, Lau LH, Pattarajierapan S, Khomvilai S, Miyata A, Shibata T, Saito Y. Protocol for a multicenter randomized controlled trial to assess the usefulness of computer-aided detection systems for colonoscopy in colorectal cancer screening in the Asia-Pacific region (project CAD\/NCCH2217). Jpn J Clin Oncol. 2025 Mar 9:hyaf043. doi: 10.1093\/jjco\/hyaf043. Epub ahead of print. PMID: 40057966.\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nATLAS\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u306e\u6700\u524d\u7dda, \u4e2d\u6751\u5065\u4e00, CPHI Japan, 2024\/4\/19, \u56fd\u5185, \u53e3\u982d.\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nATLAS Activity Report, Kenichi Nakamura, CRM Trial Connect 2024 Pre-Confrence, 2024\/5\/8, \u6d77\u5916, \u53e3\u982d.\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nATLAS project\u306b\u3088\u308b\u30a2\u30b8\u30a2\u81e8\u5e8a\u8a66\u9a13\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u69cb\u7bc9, \u4e2d\u6751\u5065\u4e00, \u7b2c37\u56de\u6297\u60aa\u6027\u816b\u760d\u958b\u767a\u30d5\u30a9\u30fc\u30e9\u30e0, 2025\/2\/15, \u56fd\u5185, \u53e3\u6f14\u3002\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\n\u5e0c\u5c11\u304c\u3093\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u958b\u767a\u6226\u7565\uff1bMASTER KEY\u30d7\u30ed\u30b8\u30a7\u30af\u30c8,\u5927\u718a\u3072\u3068\u307f\uff0c\u6e9d\u53e3\u5343\u6625\uff0c\u7b2c83\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0e2024\/9\/19, \u56fd\u5185\u3001\u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nRegional Network for Clinical Trials -ATLAS-,\u5bfa\u7530\u3000\u53c2\u7701, the Indonesia International Cancer Conference (IICC), 2024\/10\/5, \u6d77\u5916, \u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nRegional Network for Clinical Trials -ATLAS-, \u5bfa\u7530\u3000\u53c2\u7701, 27th Ho Chi Minh City Annual Conference in cancer control and prevention, 2024\/12\/5, \u6d77\u5916, \u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\n\u30bf\u30a4\u3092\u4e2d\u5fc3\u3068\u3059\u308b\u30a2\u30b8\u30a2\u306b\u304a\u3051\u308bATLAS\u306e\u53d6\u308a\u7d44\u307f\u306b\u3064\u3044\u3066, \u5bfa\u7530\u3000\u53c2\u7701, \u7b2c9\u56de \u65e5\u85ac\u9023\u56fd\u969b\u59d4\u54e1\u4f1a\u30a2\u30b8\u30a2\u30bb\u30df\u30ca\u30fc\uff08\u30bf\u30a4\uff09, 2024\/9\/26, \u56fd\u5185, \u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nAsia Clinical Trials and Collaboration with Asian Regulatory Authorities – Collaboration to Improve Clinical Trial Capacity in Asia – , \u5bfa\u7530\u3000\u53c2\u7701, International Symposium for Asia Regulatory Coordination ~ Memoriam for Establishment of PMDA Asia Office ~, 2024\/8\/29, \u6d77\u5916, \u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nICR web and training program-ATLAS-, \u5bfa\u7530\u3000\u53c2\u7701, ARISE 3rd Annual Meeting, 2024\/11\/21, \u6d77\u5916, \u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nClinical landscape of precision oncology for rare cancers among diverse Asian populations: Insights from the MASTER KEY registry. \u6e9d\u53e3\u5343\u6625, ASCO Annual Meeting 2024, 2024\/5\/30-6\/3, \u6d77\u5916, \u30dd\u30b9\u30bf\u30fc\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nA pan-Asia platform study for precision medicine: MASTER KEY Asia, \u6e9d\u53e3\u5343\u6625, 2024 National Cancer Congress Malaysia, 2024\/6\/22, \u6d77\u5916, \u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nTreatment development for rare cancers: MASTER KEY Project and ATLAS project, \u6e9d\u53e3\u5343\u6625, Perak Annual Medical Research Conference 2024, 2024\/10\/4, \u6d77\u5916, \u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\n\u5e0c\u5c11\u304c\u3093\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u7814\u7a76\u3068\u30a2\u30b8\u30a2\u3078\u306e\u5c55\u958bMASTER KEY Asia, \u6e9d\u53e3\u5343\u6625, \u7b2c8\u56de\u300c\u88fd\u85ac\u4f01\u696d\u5411\u3051 \u304c\u3093\u7d71\u8a08\u306b\u95a2\u3059\u308b\u8abf\u67fb\u30fb\u52c9\u5f37\u4f1a\u300d, 2025\/2\/21, \u56fd\u5185, \u53e3\u982d\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nGenomic profiling of circulating tumor DNA in ovarian cancer in Asia: NCCH1905\/A-TRAIN study, Lin-Hung Wei, Yuki Kojima… Kenichi Nakamura, Kan Yonemori, the 13th AACR-JCA Joint Conference. 2025\/2\/2, \u6d77\u5916, \u30dd\u30b9\u30bf\u30fc.\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nEnglish<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nPositivity rates of FGFR2 fusion gene or rearrangement and genetic profiling in Asian Cholangiocarcinoma, Yuta Maruki… Takuji Okusaka, ESMO Asia, 2024\/12\/6, \u6d77\u5916, \u30dd\u30b9\u30bf\u30fc.\u00a0<\/td>\r\n<\/tr>\r\n
FY2024<\/td>\r\nJapanese<\/td>\r\n(2) Oral and Poster Presentations at Conferences and Symposia<\/td>\r\nTargeting FGFR2 Fusion: Gene Profiling Breakthroughs in Asian Cholangiocarcinoma, Yuta Maruki… Takuji Okusaka. JSMO, 2025\/3\/7, \u56fd\u5185, \u53e3\u6f14.\u00a0<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>","protected":false},"excerpt":{"rendered":"Year of Publication Language Category Details FY2021 English (1) Articles Published in Academic Journals and Magazines Hata T, Nakamura K, Yonemori K, Noguchi E, Watanabe M, Sohn J, Lu Y, Yap Y, Tamura K, Fujiwara Y. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs. Clin Transl […]","protected":false},"author":18,"featured_media":0,"parent":2974,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"https:\/\/atlas.ncc.go.jp\/?page_id=3887","footnotes":""},"class_list":["post-3897","page","type-page","status-publish","hentry","en-US"],"acf":{"page_preface":"A collection of achievements related to research conducted in the ATLAS project. A list of papers, conference presentations."},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/comments?post=3897"}],"version-history":[{"count":4,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3897\/revisions"}],"predecessor-version":[{"id":3942,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3897\/revisions\/3942"}],"up":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/2974"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}